NCT03591666 2018-07-19A Study of Anlotinib in Recurrent/Metastatic Head and Neck AdenocarcinomasShanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong UniversityPhase 2 Unknown51 enrolled